Tempus AI Stock (TEM) Hits New 52-Week despite Analyst Downgrade
Tempus AI (TEM) stock surged 13.4% on Thursday, hitting a new 52-week high of $86. The upside came after the health ...
Le Lézard1d
PhaseV Launches Webinar Series on AI and Data-Driven Clinical Trial Optimization
PhaseV, a pioneer in software and machine learning (ML) for advanced clinical development optimization, announced today the launch of its new webinar series exploring the latest innovations in ...
USA News Group: FDA Approval Race: AI-Powered Innovations Reshape the Healthcare Landscape
USA News Group News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, Feb. 11, 2025 /PRNewswire/ -- USA News Group News Commentary - Weeks after the monumental ...
FDA Approval Race: AI-Powered Innovations Reshape the Healthcare Landscape
Beyond Stargate's big players, a growing number of innovators have been revolutionizing healthcare by making recent ...